We have the only drug molecule that exclusively binds tauC3

TBL-100 is a potent humanized monoclonal antibody that binds tauC3 1000 times more effectively than full length tau (FLT).  TBL-100 binding to tauC3 is predicted to prevent internalization of sHMW tau by postsynaptic neurons and promote clearance through the cerebrospinal fluid (CSF) in AD patients.